Pharmaceutical firms wary of drug-related pricing polices

With the next government's inception one month away, domestic pharmaceutical industry remains cautious of President-elect Roh Moo-hyun's pledges during election - drug price contract system and gross budge system, along with the implementation of reference price system which has been withheld so far.

Many pharmaceutical firms are feared about the incoming government's plan to reduce the reim...